Pages that link to "Q36358702"
Jump to navigation
Jump to search
The following pages link to Estimating the financial cost of chronic kidney disease to the NHS in England (Q36358702):
Displaying 50 items.
- Chronic kidney disease: identification and management in primary care (Q28066936) (← links)
- The need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort study (Q28541795) (← links)
- Reducing the costs of chronic kidney disease while delivering quality health care: a call to action (Q30234324) (← links)
- Home hemodialysis: a comprehensive review of patient-centered and economic considerations (Q30399190) (← links)
- Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data (Q30486377) (← links)
- Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. (Q30585060) (← links)
- A review of the use of health examination data from the Health Survey for England in government policy development and implementation (Q30842182) (← links)
- Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust (Q33713158) (← links)
- DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease (Q33740666) (← links)
- Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit Project (Q33769037) (← links)
- Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis. (Q33790497) (← links)
- Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review (Q33821915) (← links)
- Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases (Q33838866) (← links)
- Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective (Q33947650) (← links)
- Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. (Q34264752) (← links)
- The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis (Q34325736) (← links)
- Chronic kidney disease: global dimension and perspectives (Q34347984) (← links)
- Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study (Q34647118) (← links)
- A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report (Q34677102) (← links)
- Addressing health disparities in chronic kidney disease (Q34773512) (← links)
- Active vitamin D treatment for reduction of residual proteinuria: a systematic review (Q34912750) (← links)
- A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan. (Q35095348) (← links)
- Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study (Q35097364) (← links)
- Is routine hospital episode data sufficient for identifying individuals with chronic kidney disease? A comparison study with laboratory data (Q35536667) (← links)
- Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease. (Q35573137) (← links)
- Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis (Q35576102) (← links)
- What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? (Q35583850) (← links)
- Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD. (Q35612465) (← links)
- Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health records (Q35627694) (← links)
- PAlliative Care in chronic Kidney diSease: the PACKS study--quality of life, decision making, costs and impact on carers in people managed without dialysis. (Q35688619) (← links)
- The cost of dialysis in low and middle-income countries: a systematic review (Q35840189) (← links)
- An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK. (Q36073005) (← links)
- Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital. (Q36114718) (← links)
- Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England (Q36300946) (← links)
- Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland (Q36322947) (← links)
- A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution (Q36410648) (← links)
- What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial (Q36773285) (← links)
- Estimation of the prevalence of chronic kidney disease: The results of a model based estimation in Kerman, Iran (Q36983206) (← links)
- Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT) (Q37151933) (← links)
- Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study (Q37271882) (← links)
- Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden (Q37356124) (← links)
- Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review protocol (Q37356778) (← links)
- Making an IMPAKT; Improving care of Chronic Kidney Disease patients in the community through collaborative working and utilizing Information Technology (Q37612190) (← links)
- The economic considerations of patients and caregivers in choice of dialysis modality (Q37663914) (← links)
- Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040. (Q37699809) (← links)
- Evolving importance of kidney disease: from subspecialty to global health burden (Q38111134) (← links)
- Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture (Q38114806) (← links)
- Do blood pressure levels and other patient characteristics influence native fistula patency? (Q38169766) (← links)
- mTOR controls kidney epithelia in health and disease (Q38185017) (← links)
- The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations. (Q38205939) (← links)